Publication Name	World Journal of Gastroenterology
Manuscript ID	2008
Country	Türkiye

Received	2013-01-20 19:13
Peer-Review Started	2013-01-21 15:55
To Make the First Decision	2013-02-21 18:30
Return for Revision	2013-02-25 16:12
Revised	2013-03-25 20:08
Second Decision	2013-04-09 20:21
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-04-10 07:51
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-05-16 18:34
Publish the Manuscript Online	2013-05-20 14:33

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Autobiography
Article Title	Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Wei Sun, Wei-Wei Dong, Lin-Lin Mao, Wen-Mei Li, Jian-Tao Cui, Rui Xing and You-Yong Lu
Funding Agency and Grant Number
Corresponding Author	Rui Xing, PhD, Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital/Institute, No. 52 Fucheng Road, Haidian District, Beijing 100142, China. sherry19820420@hotmail.com
Key Words	p42.3; Hepatocellular carcinoma; HepG2; Overexpression; Tumorigenicity
Core Tip	p42.3 is a novel tumor-specific and mitosis phase-dependent expression gene. It is believed to be involved in tumorigenesis in gastric and colorectal cancer. To the best of our knowledge, this is the first study to investigate the expression and function of p42.3 in hepatocellular carcinoma (HCC). We found that p42.3 promotes tumorigenicity and tumor growth in HepG2 cells and is overexpressed in HCC. These results suggest that p42.3 may act as a novel tumor biomarker and aid in the development of improved therapeutic strategies.
Publish Date	2013-05-20 14:33
Citation	Adas G, Adas M, Arikan S, Sarvan AK, Toklu AS, Mert S, Barut G, Kamali S, Koc B, Tutal F. Effect of growth hormone, hyperbaric oxygen and combined therapy on the gastric serosa. World J Gastroenterol 2013; 19(19): 2904-2912
URL	http://www.wjgnet.com/1007-9327/full/v19/i19/2904.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i19.2904

Manuscript File	2008-Review.doc
Answering Reviewers	2008-Answering reviewers.doc
Copyright License Agreement	2008-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	p42.3 ethics certification.pdf
Non-Native Speakers of English Editing Certificate	2008-Language certificate.pdf
Peer-review Report	2008-Peer review(s).pdf
Scientific Editor Work List	2008-Scientific editor work list.doc